CD34-positive cells as stem cell support after high dose therapy;HOYDOSEBEHANDLING AV KREFT VED BRUK AV CD34-POSITIVE CELLER SOM STAMCELLESTOTTE

Tidsskrift for den Norske Laegeforening

Volumn 116, Issue 21, 1996, Pages 2542-2546

  Kvalheim, Gunnar ^a   Pharo, Anne ^a   Holte, Harald ^a   Jakobsen, Erling ^a   Erikstein, Bjørn ^a   Kvaløy, Stein ^a   Beiske, Klaus ^a   Nesland, Jahn M ^a   Smeland, Erlend B ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; IFOSFAMIDE; MELPHALAN; METHOTREXATE; MITOGUAZONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIOTEPA;

ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CELL ISOLATION; CELL SEPARATION; CLINICAL ARTICLE; HUMAN; HUMAN CELL; NONHODGKIN LYMPHOMA; STEM CELL; AUTOTRANSPLANTATION; BREAST TUMOR; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOLOGY; MULTIMODALITY CANCER THERAPY; RADIATION DOSE;

ANTIGENS, CD34; BREAST NEOPLASMS; CELL SEPARATION; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; RADIOTHERAPY DOSAGE; TRANSPLANTATION, AUTOLOGOUS;

EID: 0030578732     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kvaløy S, Smeland EB. Beinmargstransplantasjon - ressurskrevende behandling i stadig utvikling. Tidsskr Nor Lægeforen 1994; 114: 302-3.
2. Benmargstransplantasjon i Norge. Helsedirektoratels utredningsserie 6-1992. Oslo: Statens helsetilsyn (Helsedirektoratet), 1992.
3. Haas R, Mohle R, Fruehauf S, Goldschmidt H, Witt B, Flentje M et al. Patient characteristics associated with sucessful mobilizing and autografting of peripheral blood progenitor cells (PBPC) in malignant lymphoma. Blood 1994; 83: 3787-94.
4. Bensinger W, Appelbaum F, Rowley S, Storb R, Sanders J, Lilleby K et al. Factors that influence collection and engraftment of autologous peripheral-blood stem cells. Blood 1995; 13: 2547-55.
5. Berenson RJ, Andrews WI, Bensinger D, Kalamatsz G, Knitter CD, Bernsten ID. CD34-positive marrow cells engraft lethally irradiated baboons. J Clin Invest 1988; 81: 951-5.
6. Smeland EB, Funderud S, Kvalheim G, Gaudernack G, Rasmussen AM, Rusten L et al. Isolation and characterization of human hematopoietic progenitor cells: an effective method for positive selection of CD34-positive cells. Leukemia 1992; 6: 845-52.
7. Berenson RJ, Bensinger WI, Hill RS, Andrews RG, Garcia-Lopez J, Kalamasz et al. Engraftment after infusion of CD34-positive marrow cells in patients with breast cancer or neuroblastoma. Blood 1991; 77: 1717-22.
8. Shpall EJ, Jones RB, Bearman SI, Franklin W, Archer PG, Curiel T et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. J Clin Oncol 1994, 12: 28-36.
9. Kvalheim G, Fodstad Ø, Pihl A, Nustad K, Pharo A, Ugelstad J et al. Elimination of B-lymphoma cells from human bone marrow: model experiments using monodisperse magnetic particles coated with primary monoclonal antibodies. Cancer Research 1987; 47: 846-51.
10. Kvalheim G, Sørensen O, Fodstad Ø, Funderud S, Kiesel S, Dorken B et al. Immunomagnetic removal of B-lymphoma cells from human bone marrow: a procedure for clinical use. Bone Marrow Transplant 1988; 3: 31-41.
11. Straka C, Dorken B, Kvalheim G. Polymerase chain reaction monitoring shows a high efficacy of clinical immunomagnetic purging in patients with centroblastic-centrocytic Non Hodgkin's lymphoma. Blood 1992; 15: 2688-90.
12. Sutherland HJ, Eaves AC, Eaves CJ. Quantitative assays of human hemopoietic progenitor cells. I: Gee AP, red. Bone marrow processing and purging: a practical quide. Boca Raton FL: CRC Press, 1991. 155-71.
13. Rusten L, Kvaløy SO, Jakobsen E, Kvalheim G, Foss Abrahamsen A, Høiby EA et al. Infeksjonsproblemer i leukopenifasen etter autolog beinmargstransplantasjon. Tidsskr Nor Lægeforen 1992; 112: 1723-6.
14. Hardwick A, Law P, Mansour V, Kulcinski D, Ishizawa L, Gee A. Development of a large-scale immunomagnetic separation system for harvesting CD34-positive cells from bone marrow. Prog Clin Biol Res 1992; 377: 583-9.
15. Corringham RE, Ho AD. Rapid and sustained allogeneic transplantation using immunoselected CD34-positive-selected peripheral blood progenitor cells mobilized by recombinant granulocyte-macrophage colony-stimulating factors. Blood 1995; 86: 2052-4.
16. Gribben JG, Freedman AS, Neuberg D, Roy DC, Blake KW, Woo DS et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N Engl J Med 1991; 28: 1525-33.
17. Brenner MK, Rill D R, Moen RC, Krance RA, Mirro J, Anderson FW et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85-6.
18. Brugger W, Bross KJ, Glatt M, Weber F, Mertelsmann R, Kanz L. Mobilization of rumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors. Blood 1994; 83: 636-40.
19. Verbik DJ, Jackson JD, Pirruccello SJ, Patil KD, Kessinger A, Joshi SS. Functional and phenotypic characterization of human peripheral blood stem cell harvests: a comparative analysis of cells from consecutive collections. Blood 1995; 85: 1964-70.
20. Brugger W, Heimfeld S, Berenson RJ, Mertelsman R, Kanz L. Reconstitution of hematopoieses after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Eng J Med 1995; 333: 283-7.